vimarsana.com

ஐரோப்பிய மருத்துவ சாதனங்கள் ஒழுங்குமுறை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Artificial Intelligence (Ai) in Medical Diagnostics Market 2021 Is Booming Globally with Top Key Players – Siemens Healthineers, GE Healthcare, Digital Diagnostics, Xilinx, InformAI, Enlitic – KSU

Investegate |Safe Orthopaedics Announcements | Safe Orthopaedics: Safe Orthopaedics announces CE mark for new Hickory screw

Safe Orthopaedics announces CE mark for new Hickory screw   TMPS next-generation range Launch of a study in Germany with Dr. Jens A.Richolt Worldwide commercialisation expected in 2022 Éragny-sur-Oise, France, May 27 th, 2021 at 8:55 a.m. CET – Safe Orthopaedics (FR0013467123 – ALSAF), a company specialising in the design, manufacture and marketing of ready-to-use technologies for back surgery, with a particular focus on the safety of emergency vertebral fractures, announced today that it has obtained CE Mark approval for Hickory, a new treatment for the management of osteoporotic patients. Osteoporosis is a global clinical issue. This disease, which affects a growing number of people, mainly affects those over 50 years of age and has consequences for the treatment of spinal pathologies. Safe Orthopaedics, which recently announced the launch of Sycamore for the treatment of vertebral fractures, is now offering Hickory for the treatment of other pathologies requiring pe

Safe Orthopaedics announces CE mark for new Hickory screw

Safe Orthopaedics announces CE mark for new Hickory screw TMPS next-generation range Launch of a study in Germany with Dr. Jens A.Richolt Worldwide commercialisation expected in 2022 Éragny-sur-Oise, France, May 27 th, 2021 at 8:55 a.m. CET - Safe Orthopaedics (FR0013467123 - ALSAF), a company specialising in the design, manufacture and marketing of ready-to-use technologies for back surgery, with a particular focus on the safety of emergency vertebral fractures, announced today that it has obtained CE Mark approval for Hickory, a new treatment for the management of osteoporotic patients. Osteoporosis is a global clinical issue. This disease, which affects a growing number of people, mainly affects those over 50 years of age and has consequences for the treatment of spinal pathologies. Safe Orthopaedics, which recently announced the launch of Sycamore for the treatment of vertebral fractures, is now offering Hickory for the treatment of other pathologies requiring pedicle scre

Safe Orthopaedics announces CE mark for Sycamore

Safe Orthopaedics announces CE mark for Sycamore May 24, 2021 02:34 ET | Source: Safe Orthopaedics Safe Orthopaedics Éragny, FRANCE  Very dynamic market segment  Worldwide commercialization expected in 2022 Éragny-sur-Oise, France, On May 24, 2021 à 8:35 CET – Safe Orthopaedics (FR0013467123 – ALSAF), a holding of the Safe Group (composed of Safe Orthopaedics, a company specializing in the design, manufacturing and marketing of single-use technologies for spinal surgeries, and Safe Medical (Ex-LCI medical), integrated subcontractor for orthopedic medical devices, today announces the CE mark for Sycamore, a new treatment for the management of patients with one or more osteoporotic fractures. Osteoporotic fracture is a global clinical issue. Driven by the aging population and the dynamic lifestyle of those 50 years and older, the number of vertebral fractures has increased significantly over the past two decades.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.